Antibiotics are used to treat or prevent bacterial infections, and sometimes protozoan infections, having saved thousands of lives. The discovery and application of antibiotics added 5-10 years to the life expectancy of the average American. However, inappropriate antibiotic treatment and overuse of antibiotics have contributed to the emergence of antibiotic-resistant bacteria. Some strains have become resistant to practically all of the commonly available agents (multidrug resistance), being one of the most important current threats to public health. Therefore, there is a critical need to develop new antimicrobials effective against these difficult-to-treat multidrug-resistant pathogens.
TargetMol’s Anti-Bacterial Compound Library collects various antibiotics and antibacterial compounds with unique structures by fully considering the bioactivity and unique structure of selected compounds. This library, consisting of 1429 small molecules with antibacterial activity, is an effective tool for antibiotics and antibacterial drug development.
|30 μL * 10 mM (in DMSO)||11500.00|
|100 μL * 10 mM (in DMSO)||25700.00|
|250 μL * 10 mM (in DMSO)||44299.00|